Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Indirect treatment comparisons of avapritinib versus midostaurin for patients with advanced systemic mastocytosis.
Future Oncol. 2022 Apr;18(13):1583-1594. doi: 10.2217/fon-2021-1509. Epub 2022 Feb 4.
Future Oncol. 2022.
PMID: 35114819
The avapritinib versus midostaurin adjusted hazard ratio for OS was 0.44 (95% CI: 0.25-0.76), and the adjusted odds ratios for ORR and CR were 4.06 (95% CI: 3.09-5.33) and 9.56 (95% CI: 0.97-93.81), respectively. Conclusion: The results suggest that avapritinib improves su …
The avapritinib versus midostaurin adjusted hazard ratio for OS was 0.44 (95% CI: 0.25-0.76), and the adjusted odds ratios for ORR an …
The efficacy of alcelaphine herpesvirus-1 (AlHV-1) immunization with the adjuvants Emulsigen® and the monomeric TLR5 ligand FliC in zebu cattle against AlHV-1 malignant catarrhal fever induced by experimental virus challenge.
Lankester F, Lugelo A, Werling D, Mnyambwa N, Keyyu J, Kazwala R, Grant D, Smith S, Parameswaran N, Cleaveland S, Russell G, Haig D.
Lankester F, et al. Among authors: smith s.
Vet Microbiol. 2016 Nov 15;195:144-153. doi: 10.1016/j.vetmic.2016.09.019. Epub 2016 Sep 23.
Vet Microbiol. 2016.
PMID: 27771060
Free PMC article.
Item in Clipboard
Cite
Cite